In April 2008, Amanda Watts’ dermatologist prescribed a 20-week course of Solodyn, a time-release form of minocycline. Two years later, Watts was prescribed a second 20-week course of the drug.
Watts was granted the okay to pursue a consumer-fraud claim against the Medicis Pharmaceutical Corp. drug company. Watts alleged that her doctor issued her a Medicis drug-discount card that said the “safety of using (Solodyn) longer than 12 weeks had not been studied and was not known.”
“She was treated and recovered from hepatitis, but doctors expect she’ll have lupus for the rest of her life,” court documents state.
Mick Levin, the Phoenix attorney who represents Watts, said she began taking the drug when she was 16, and will have to investigate what information Watts’ medical provider had about the potential long-term harms associated with the said drug.
The state’s high court is allowing Watts to follow through with her claim that Medicis did not provide adequate warning about potential dangers of using Solodyn. However, if the drug company can prove it gave adequate warning to Watts’ health provider, then the company will have fulfilled its requirement and will be entitled to summary judgment.
Watts claimed she never received Medicis’ full prescribing information, which warns “that long-term use of minocycline has been associated with “drug-induced lupus-like syndrome, autoimmune hepatitis and vasculitis.”
Read more about the case here.